# Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C

Study · id `cardio:ct-nct01381172` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01381172](<https://clinicaltrials.gov/study/NCT01381172>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01381172

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT01381172. Randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2019-03-19 (actual). Results posted on 2021-09-17.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT01381172, source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)
- Start date: 2011-01 (registry gives no type) (ClinicalTrials.gov record NCT01381172, source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)
- Primary completion: 2019-03-19 (actual) (ClinicalTrials.gov record NCT01381172, source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)
- Completion: 2019-03-19 (actual) (ClinicalTrials.gov record NCT01381172, source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)
- Results first posted: 2021-09-17 (ClinicalTrials.gov record NCT01381172, source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)
- Countries: United States; Czechia; Germany (ClinicalTrials.gov record NCT01381172, source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01381172-2021-09-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
- Acronym: FIX-HF-5C
- Condition: NYHA Class III Heart Failure
- Condition: NYHA Class IV Heart Failure
- Intervention (Device): Optimizer System
- Intervention (Other): No intervention: Optimal medical therapy
- Lead sponsor: Impulse Dynamics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Impulse Dynamics (`cardio:org-impulse-dynamics`)

## Provenance

Content hash: 3dc3143bb12f61fb85da7f798cf5f846de3c239f3ca0316773a1e3f399fa5048
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
